Search Result "XL765"

Between Bench and Bed Side: PI3K Inhibitors

Journal: Current Molecular Pharmacology
Volume: 3 Issue: 2 Year: 2010 Page: 79-90
Author(s): Luis Paz-Ares, Amancio Carnero

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2686-2714
Author(s): S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke, P. Workman

Recent Developments in Targeted Therapies of the RAF-MEK and PI3KAKT Pathways in Cancer Treatment

Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 3 Year: 2012 Page: 205-217
Author(s): Lobke G.M. Cremers,Johannes Boonstra

Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 10 Year: 2013 Page: 1552-1564
Author(s): Asif Khurshid Qazi,Aashiq Hussain,Abid Hamid,Yasrib Qurishi,Rabiya Majeed,Mudassier Ahmad,Rauf Ahmad Najar,Javeed Ahmad Bhat,Shashank Kumar Singh,Mohmmad Afzal Zargar,Shakir Ali,Ajit Kumar Saxena

Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 26 Year: 2014 Page: 3048-3056
Author(s): K.D. Tang,Ming-Tat Ling

Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 918-926
Author(s): L. Porcelli,A.E. Quatrale,P. Mantuano,N. Silvestris,J.F. Rolland,L. Biancolillo,A. Paradiso,A. Azzariti

Targeting mTOR Pathways in Human Malignancies

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2766-2777
Author(s): Angelica Fasolo,Cristiana Sessa

Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin

Journal: Current Cancer Drug Targets
Volume: 16 Issue: 4 Year: 2016 Page: 288-304
Author(s): Zhipeng Zou,Juan Chen,Jun Yang,Xiaochun Bai

Review Article

The Upshot of PI3K Inhibitors as Anticancer Arsenal: A Short Review

Journal: Current Bioactive Compounds
Volume: 14 Issue: 4 Year: 2018 Page: 331-346
Author(s): Farheen Shamsi,Mohammad M. A. Rizvi,Mohammad Abid

PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4326-4341
Author(s): P. Wu, Y.-Z. Hu

Previous   Next

Go To   Results 1 - 1 of 56

Filter Result

Volume Year
Content Type
© 2023 Bentham Science Publishers | Privacy Policy